Compare HROW & VTOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | VTOL |
|---|---|---|
| Founded | 1998 | 1948 |
| Country | United States | United States |
| Employees | 373 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 2011 |
| Metric | HROW | VTOL |
|---|---|---|
| Price | $31.15 | $43.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $69.86 | $58.00 |
| AVG Volume (30 Days) | ★ 842.7K | 225.1K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | N/A | ★ 34.58 |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $1,490,512,000.00 |
| Revenue This Year | $31.62 | $11.64 |
| Revenue Next Year | $50.77 | $5.59 |
| P/E Ratio | ★ N/A | $95.36 |
| Revenue Growth | N/A | ★ 5.30 |
| 52 Week Low | $25.21 | $28.03 |
| 52 Week High | $54.98 | $50.38 |
| Indicator | HROW | VTOL |
|---|---|---|
| Relative Strength Index (RSI) | 32.55 | 37.43 |
| Support Level | $29.15 | $41.17 |
| Resistance Level | $41.67 | $50.07 |
| Average True Range (ATR) | 1.87 | 1.52 |
| MACD | -0.85 | -0.32 |
| Stochastic Oscillator | 18.64 | 25.92 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.